Cooley, Ropes and Wachtell lead as Pfizer recovers from Allergan fall-out
Pfizer's�$14bn proposed acquisition�comes�just months after its�mega merger with Allergan collapsed. 4 Aug: M&A fees revealed: Who is cashing in on the biggest deals of 2016?
Ropes & Gray is advising Pfizer on its $14bn proposed acquisition of pharmaceutical company Medivation - just a few months after its�mega merger with Allergan collapsed.
Pfizer turned to Ropes M&A partner Chris Comeau in Boston, as well as securities and public companies partner Paul Kinsella and t...